p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Testicular cancers respond favorably to chemotherapy with the platinum-containing drug cis-diamminedichloroplatinum(II) (cisplatin). One factor that could explain the efficacy of cisplatin is the low frequency of p53 mutations observed in this tumor type. The present study examines the p53-mediated...
Guardado en:
| Publicado en: | Proc Natl Acad Sci U S A |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
National Academy of Sciences
1998
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27612/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9600935/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.11.6163 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|